Radiation-induced oxidative injury of the ileum and colon is alleviated by glucagon-like peptide-1 and -2  by Deniz, Mustafa et al.
w.sciencedirect.com
J o u r n a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 8 ( 2 0 1 5 ) 2 3 4e2 4 2HOSTED BY Available online at wwScienceDirect
Journal of Radiation Research and Applied
Sciences
journal homepage: ht tp: / /www.elsevier .com/locate/ j r rasRadiation-induced oxidative injury of the ileum
and colon is alleviated by glucagon-like peptide-1
and -2Mustafa Deniz a, Beste M. Atasoy b, Faysal Dane c, Gu¨ray Can d,
Can Erzik e, S‚ule C¸etinel
f, Berrak C¸. Yegen g,*
a C¸anakkale Onsekiz Mart University School of Medicine, Department of Physiology, C¸anakkale, Turkey
b Marmara University School of Medicine, Department of Radiation Oncology, _Istanbul, Turkey
c Marmara University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, _Istanbul,
Turkey
d Abant _Izzet Baysal University School of Medicine, Department of Internal Medicine, Division of Gastroenterology,
Bolu, Turkey
e Marmara University School of Medicine, Department of Medical Biology, _Istanbul, Turkey
f Marmara University School of Medicine, Department of Histology and Embryology, _Istanbul, Turkey
g Marmara University School of Medicine, Department of Physiology, _Istanbul, Turkeya r t i c l e i n f o
Article history:
Received 20 December 2014
Accepted 22 January 2015
Available online 9 February 2015
Keywords:
GLP-1
GLP-2
Radiation-enteritis
Myeloperoxidase
Glutathione* Corresponding author. Marmara University
No. 9/1, Maltepe 34854, _Istanbul, Turkey. Te
E-mail address: byegen@marmara.edu.tr
Peer review under responsibility of The E
http://dx.doi.org/10.1016/j.jrras.2015.01.010
1687-8507/Copyright© 2015, The Egyptian Soc
open access article under the CC BY-NC-ND lia b s t r a c t
Purpose: The present study was conducted to characterize the possible therapeutic effects
of glucagon-like peptide (GLP)-1 and GLP-2 against oxidative damage in the ileum and colon
of irradiated rats.
Methods and materials: Sprague-Dawley rats of both sexes received either a single dose of
GLP-1 (0.1 nmol/kg, intraperitoneally, ip; n ¼ 6) 10 min before abdominal irradiation (IR) or
two consecutive doses of GLP-2 (7 nmol/kg, ip; n ¼ 6) at 30 and 10 min before IR, while
another group was administered vehicle (n ¼ 6) 10 min before IR. Control rats (n ¼ 6)
received vehicle treatment without IR. On the fourth day of IR, samples from ileum and
colon were removed for histological analysis, for the determination of myeloperoxidase
(MPO) activity, malondialdehyde (MDA) and glutathione (GSH) levels, as well as DNA
fragmentation ratio, an index of apoptosis.
Results: IR-induced oxidative injury in the colonic tissue of vehicle-treated rats, evidenced
by elevated MDA levels and MPO activity, as well as depleted colonic GSH levels, was
reversed by GLP-2, while GLP-1 reduced IR-induced elevations in colonic MDA levels. IR-
induced injury with elevated ileal MDA levels was reduced by GLP-1, while replenish-
ment in GSH was observed in GLP-2-treated rats.
Conclusion: Current findings suggest that GLP-1 and GLP-2 appear to have protective roles in
the irradiation-induced oxidative damage of the gut by inhibiting neutrophil infiltration
and subsequent activation of inflammatory mediators that induce lipid peroxidation.School of Medicine, Department of Physiology, Bas‚ ıbu¨yu¨k mah., Maltepe Bas‚ ıbu¨yu¨k yolu
l.: þ90 216 4212222.
(B.C¸. Yegen).
gyptian Society of Radiation Sciences and Applications.
iety of Radiation Sciences and Applications. Production and hosting by Elsevier B.V. This is an
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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During radical pelvic or abdominal radiotherapy of the geni-
tourinary or lower gastrointestinal (GI) tumors, exposure of
healthy intestinal tissues to radiation often results in acute
and long-term GI symptoms due to the physical disruption of
the sensitive regenerative epithelium of the intestinal mucosa
(Andreyev, 2007; Molla & Panes, 2007; Rubio & Jalnas, 1996).
Although the pathogenesis of radiation enteritis is not clear, it
is presumed to be an inflammatory process in which various
mediators such as eicosanoids, cytokines, and reactive oxygen
species (ROS) take place (Linard, Ropenga, Vozenin-Brotons,
Chapel, & Mathe, 2003; MacNaughton, 2000). It has long been
recognized that the most critical target of irradiation passing
through living tissues is the DNA (Daly, Bertagnoli, De Cosse,&
Morton, 1999). Additionally, lipids and proteins present in the
structure of the cells are also attacked by ROS generated
following irradiation (Agrawal, Chandra, & Kale, 2001).
Consequently, in order to control the acute gastrointestinal
injury and to reduce the impact of long-term effects of
radiotherapy on gastrointestinal function, dietary, pharma-
cological and physical interventions as well as optimization of
radiotherapy techniques are considered (Yeoh, 2008). Current
biological modifiers targeting oxidative damage for radiopro-
tection have a limited success, because oxidative tissue injury
due to ionizing radiation ultimately begins by radiolytic hy-
drolysis and formation of ROS (Vijayalaxmi, Tan, Herman, &
Thomas, 2004). Thus, to boost defense mechanisms against
oxidative injury, there is a need for new potent and non-toxic
antioxidant compounds.
Glucagon like peptide-1 (GLP-1) and GLP-2 represent the
major secretory peptides derived from the posttranslational
processing of the proglucagon gene expressed in the enter-
oendocrine L cells localized in the intestine with multiple
local and systemic actions (Drucker, 2005). Numerous animal
studies have suggested that GLP-2 is a potent intestinal
mitogen in rodents (Dube & Brubaker, 2007; Estall & Drucker,
2006) and it was shown to increase absorptive surface area
and intestinal weight by stimulating epithelial cell prolifera-
tion, inhibiting apoptosis and leading to enlarged crypts and
villi. GLP-2 also increases the capacity for nutrient absorption
and increases the activity of nutrient transporters and
epithelial brush-border digestive enzymes (Martin, Wallace,
& Sigalet, 2004). Independent of its proliferative actions,
GLP-2 has anti-inflammatory effects (Sigalet et al., 2007).
Similarly, GLP-1 has attenuated inflammation-induced
microvascular permeability and protected mesenteric endo-
thelium (Dozier et al., 2009). GLP-1 was shown to ameliorate
myocardial ischemia/reperfusion injury in rabbits (Matsubara
et al., 2009), with a possible protective effect directly on
myocytes (Ban et al., 2008). Similarly, GLP-1 has exerted an
anti-apoptotic effect in isolated pancreatic beta-cells
(Drucker, 2003).Based on these reports, this study was designed to char-
acterize the possible therapeutic effects of GLP-1 and GLP-2
against irradiation-induced oxidative damage of the ileum
and colon in rats by evaluating the extent of tissue injury
through biochemical and histological analyses.2. Materials and methods
2.1. Animals
Sprague Dawley rats of both sexes (240e280 g) were ob-
tained from Marmara University Animal Center
(DEHAMER). They were kept at a constant temperature of
22 ± 2 C with lightedark cycles of 12 h and fed a standard
diet and water ad libitum. The experimental protocol was
approved by the Marmara University Animal Care and Use
Committee.
2.2. Experimental design
After an overnight fasting, anesthetized rats (ketamine,
100 mg/kg and chlorpromazine, 12.5 mg/kg, intraperitone-
ally; ip) were irradiated with a linear accelerator (LINAC,
Saturne 42, 800 series, General Electric, Buc, France) pro-
ducing 6 MV photons at a focus 100 cm distant from skin,
where each animal received an 11-Gy ionizing radiation (IR)
to whole abdominal area. GLP-1 and GLP-2 (Sigma Chemi-
cal, St. Louis, MO) were prepared in 0.1% bovine serum al-
bumin (BSA, Sigma Chemical). The rats received ip either a
single dose of GLP-1 (0.1 nmol/kg; n ¼ 6) 10 min before the IR
or two consecutive doses of GLP-2 (7 nmol/kg; n ¼ 6) at 30
and 10 min before IR, while another group of animals were
given vehicle (BSA; n ¼ 6) 10 min before they were irradi-
ated. Rats were returned to their home cages following the
irradiation procedure. Control rats (n ¼ 6) received BSA
without IR.
Rats were decapitated on the 4th day of IR, and samples
from ileum and colon were fixed in formaldehyde for histo-
logical analysis, while additional ileal and colonic samples
were stored at 80 C for the determination of myeloperox-
idase (MPO) activity, malondialdehyde (MDA), glutathione
(GSH) levels and DNA fragmentation.
2.3. Measurement of tissue myeloperoxidase activity
MPO is an essential enzyme for normal neutrophil function,
which is released from the stimulated neutrophils along with
other tissue-damaging substances (Kettle & Winterbourn,
1997). MPO activity was measured in tissues in a procedure
similar to that documented by Hillegas, Griswold, Brickson,
and Allbrightson-Winslow (1990). Tissue-associated myelo-
peroxidase (MPO) activity was determined in 0.2e0.3-g
samples. Tissue samples were homogenized in 10 volumes
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7.4). The homogenate was centrifuged at 12,000 rpm for
10 min at 4 C, and the supernatant was discarded. The pellet
was then re-homogenized with an equivalent volume of
50 mM K2HPO containing 0.5% (wt/vol) hexadecyl-
trimethylammonium hydroxide (Sigma). MPO activity was
assessed by measuring the H2O2-dependent oxidation of o-
dianisidine$2HCI. One unit of enzyme activity is defined as
amount of the MPO present that causes a change in absor-
bance of 1.0 min1 at 460 nm and 37 C (Bradley, Priebat,
Christerser, & Rothstein, 1982).
2.4. Measurement of tissue malondialdehyde (MDA) and
glutathione (GSH) levels
Tissue samples were homogenized in 10 volumes of ice-cold
10% trichloracetic acid and centrifuged at 3000 rpm for
15 min at 4 C. Supernatant was removed and re-centrifuged
at 10,000 rpm at 4 C for 8 min. The supernatant was trans-
ferred to a test tube containing an equal volume of TBA (0.67%
w/v), and this mixture was then heated to 90 C and main-
tained at that temperature for 15min. TheMDA concentration
for each specimen was determined using a spectrophotom-
eter based on its absorbance at 532 nm, and was expressed as
nmol/g tissue (Beuge & Aust, 1978). GSH measurements were
performed using a modification of the Ellman procedure
(Beutler, 1975). Briefly, after centrifugation at 3000 rpm for
10 min, 0$5 ml supernatant was added to 2 ml 0$3 mol/l
Na2HPO4$2H2O solution. A 0$2 ml solution of dithiobisni-
trobenzoate (0$4 mg/ml 1% sodium citrate) was added and the
absorbance at 412 nm was measured immediately after mix-
ing. GSH levels were calculated using an extinction coefficient
of 1$36  105 M/cm. Results are expressed in mmol GSH/g
tissue.
2.5. Histopathological analysis
For light microscopic investigations, both ileum and colon
samples were fixed in 10% formaldehyde, dehydrated in
alcohol series, cleared in toluen end embedded in paraffin.
Paraffin sections (5 mm) were stained with hematoxylin and
eosin (H&E) and examined under a photomicroscope
(Olympus BH 2, Tokyo, Japan). All tissue sections were
examined microscopically for the characterization of histo-
pathological changes by an experienced histologist (S.C.) who
was unaware of the treatment conditions. Assessment of the
IR-induced injury was performed semi-quantitatively using
the criteria given in Table 1.
2.6. DNA fragmentation assay
Mucosal samples from both tissues were homogenized in 10
volumes of a lysis buffer (5 mM TriseHCl, 20 mM ethylene
diamine tetra-acetic acid (EDTA) and 0$5% (v/v) t-octylphe-
noxypolyethoxyethanol (Triton-X 100; pH 8.0)). Two separate
samples of 1 ml each, were taken from the sample and
centrifuged at 25,000 g for 30 min to separate the intact chro-
matin in the pellet from the fragmented DNA in the superna-
tant (Wyllie, 1980). The supernatant was saved and the pellet
was re-suspended in 1 ml triseethylenediaminetetraacetate
J o u rn a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 8 ( 2 0 1 5 ) 2 3 4e2 4 2 237buffer (pH 8$0; 10mM:1mM). Both the supernatant and the re-
suspended pellet were then assayed for DNA content deter-
mination by the diphenylamine reaction described by Burton
(Burton, 1956).
2.7. Statistics
All values are given as means ± SE. Groups of data were
compared with ANOVA followed by Tukey's multiple com-
parison test and the significance level was set at p < 0.05.3. Results
Histopathological analysis revealed that irradiation resulted in
severe degeneration of both ileum and colon. Detachments of
epithelium extending to submucosa, severe foamy degenera-
tion inglandularepitheliumwith lossof cellswasprominent in
the BSA-treated IR group (Figs. 1b and 2b), while the control
group demonstrated a regular morphology of ileum and colon
(Figs. 1a and 2a). In the ileal tissues of the GLP-1-treated IR
group, therewas a prominent reorganization of epithelial cells
with aberrant vacuolization (Fig. 1c). In the colonic tissues of
the GLP-1-treated IR group, the epithelial alignment and lam-
ina propria showed a prominent recovery besides a significant
re-production of mucus from the goblet cells (Fig. 2c). In the IRFig. 1 eMicrographs of the ileal tissues. A. Control group, regula
(*), B. Vehicle-treated irradiated group, the epithelium showed d
degeneration of the glands (*) accumulation of leukocytes in lami
the epithelial cells appear foamy but they demonstrate promin
mitotic cell in the epithelium (arrow-insert), D. GLP-2-treated ir
(arrowheads), the glandular structures show re-epithelization in
£200, inserts £400.group treated with GLP-2, the ileal tissues showed a marked
regeneration in the epithelium, whereas in the glandular cells
the regeneration was less than that of the GLP-1-treated IR
group, with still ongoing leukocyte accumulation and conges-
tion in the lamina propria (Fig. 1d). In the colonic epithelium, a
realigned epithelium along with an overproduction of mucus
was observed in both epithelium and glands (Fig. 2d).
Microscopic scores of ileal and colonic tissues, designating
IR-induced mucosal damage, were very high in vehicle-
treated IR group (3.33 ± 0.09 and 3.45 ± 0.10, where 4 is the
maximum score) showing degeneration as compared to tis-
sues of control rats (p < 0.001; Fig. 3a). However, the scores of
ileal and colonic tissues in the GLP-1- and GLP-2-treated IR
groups were significantly lower (p < 0.01) than those of the
BSA-treated IR group. Similarly, mucosal DNA fragmentation
percentage, an indicator of apoptosis, was significantly
elevated in the ileum and colon of BSA-treated IR rats
(p < 0.001; Fig. 3b). GLP-1 and GLP-2 treatments given before
irradiation significantly decreased DNA fragmentation ratio in
both the ileum (p < 0.01 and p < 0.01) and colon (p < 0.001 and
p < 0.05).
MDA levels in the ileal and colonic tissues of the irradiated
group that has received vehicle pretreatment were signifi-
cantly higher than those of the non-irradiated control group
(Fig. 4a). Pretreatment with GLP-1 reduced IR-induced eleva-
tion in MDA levels of both ileal (p < 0.05) and colonic (p < 0.01)r epithelium (arrow) with goblet cells and intestinal glands
etachments in most of the areas (arrowheads), severe
na propria (arrow-insert), C. GLP-1-treated irradiated group,
ent rearrangement (arrowheads) besides the glands (*), the
radiated group, the epithelium retains its integrity
the gland where most of the cells lack nuclei (*-insert); HE,
Fig. 2 e Micrographs of the colonic tissues. A. Control group, regular colonic epithelium (arrow) and glands (*), B. Vehicle-
treated irradiated group, with severe degeneration of colonic tissue (arrows) extending to muscularis mucosa, loss in the
integrity of glandular cells (*), C. GLP-1-treated irradiated group, re-organized epithelium (arrow), crypts (arrowhead) and
glands (*) with high density of vacuolization (broken arrow), D. GLP-2-treated irradiated group, epithelial re-organization,
high density of vacuoles in glandular cells (*); HE, £200.
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the colonic tissues of GLP-2-pretreated rats that were irradi-
ated (p < 0.05), while the reduction in ileal MDA level by GLP-2
treatment was not significant. In accordance with the MDA
results, irradiation of BSA-treated rats caused depletion of
GSH in both ileum and colon (p < 0.001; Fig. 4b). However, GLP-
1 pretreatment did not change the reduced GSH levels of
either ileal or colonic tissues of irradiated rats, while the GSH
levels in both tissues of irradiated and GLP-2-pretreated-rats
were not different than those of the control levels.
MPO activity, an indicator of tissue neutrophil infiltration,
was significantly elevated in both the ileal and colonic tissues
of all the irradiated groups (p < 0.05e0.01) as compared to the
tissues of non-irradiated control group (Fig. 4c). Neither GLP-1
nor GLP-2 pretreatment did not alter IR-induced ileal injury. In
contrary, pretreatment with GLP-2, but not with GLP-1,
significantly decreased IR-induced elevation in colonic MPO
activity (p < 0.01).4. Discussion
The results of the current study have demonstrated that
irradiation-induced oxidative damage of the ileum and colon
is ameliorated by both GLP-1 and GLP-2 pretreatments. Both
peptides were effective in improving the morphological
changes and reducing apoptosis in the ileal and colonictissues. IR-induced oxidative injury in the colonic tissue, evi-
denced by elevated MDA levels and MPO activity, as well as
depleted GSH levels was reversed by GLP-2, while GLP-1 only
reduced the IR-induced elevation in MDA levels. Ileal injury
due to IR, as evident with elevatedMDA levels, was reduced by
GLP-1, but not by GLP-2. On the other hand, ileal GSH replen-
ishment was only reached by GLP-2 treatment. Current find-
ings suggest that these proglucagon gene-derived peptides
appear to have varying degrees of protective roles in the
irradiation-induced oxidative damage of the gut by inhibiting
neutrophil infiltration and subsequent activation of inflam-
matory mediators that induce lipid peroxidation.
Ionizing radiation is currently one of the main modalities
in cancer therapy. The incidence of radiation enteritis is
increasing because of the current trend of combined adjuvant
chemotherapy and radiation strategies (Ooi, Tjandra,& Green,
1999). Radiation enterocolitis is one of the most feared and
potentially life-threatening complications of abdominal and
pelvic radiation affecting the quality of patients' life (Mann,
1991). In high doses, cell death may occur as a direct conse-
quence of GI epithelial damage (Hauer-Jensen, 1990), which is
progressive in nature and its treatment is non-rewarding.
Therefore, the morbidity and mortality due to complications
of radiation enterocolitis remain high (Earnest & Trier, 1989).
Radiobiologists have recognized that themost critical target of
ionizing radiation passing through living tissues is the DNA in
the nucleus and mitochondria of most cells. Exposure of cells
Fig. 3 e Microscopic damage scores (a) and DNA
fragmentation ratios (%) (b) in the ileum and colon of rats
treated with, GLP-1 or GLP-2 before they were irradiated
(------). **p < 0.01, ***p < 0.001 compared to non-irradiated
control group; þp < 0.05, þþp < 0.01, þþþp < 0.01 compared
to saline-treated irradiated group.
Fig. 4 e Malondialdehyde (MDA) and glutathione (GSH)
levels, and myeloperoxidase (MPO) activity in the ileum
and colon of rats treated with vehicle (saline), GLP-1 or
GLP-2 before they were irradiated (------). *p<0.05, **p<0.01,
***p<0.001, compared to non-irradiated control group;
þp < 0.05, þþp < 0.01, compared to vehicle-treated
irradiated group.
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oxidative damages to DNA by both direct and indirect mech-
anisms (Zhou et al., 2006). About 60e70% of cellular DNA
damage produced by ionizing radiation is caused by OH,
formed from the radiolysis of water (Ward, 1988). These occur
primarily by interaction of free radicals with DNA bases and,
to a lesser extent, with DNA sugars (Karbownik& Reiter, 2000).
Besides DNA, lipids and proteins are also attacked by free
radicals induced by ionizing radiation (Vijayalaxmi, Herman,
& Meltz, 1998). The radio-protectors can elicit their action by
various mechanisms, such as suppression of the formation or
detoxification of the radiation-induced species, target stabili-
zation and enhancing the repair and recovery processes (Nair,
Parida, & Nomura, 2001). Since rapidly proliferating intestinal
crypt cells are particularly sensitive to radiation, various
chemicals and nutrients have been used in the past for pre-
vention and treatment of adverse effects of radiation on in-
testinal mucosa. However, there is still need for new potent
anti-inflammatory agents in attenuating the deleterious ef-
fects of irradiation on gut epithelium.
Although the number of identifiable cells undergoing
spontaneous apoptosis in the normal intestinal crypt
compartment is low, intestinal injury after exposure to
ionizing radiation results in marked induction of apoptosis in
the crypt compartment (Coopersmith & Gordon, 1997; Ijiri &
Potten, 1983; Watson & Pritchard, 2000). When the animalswere exposed to low-dose radiation (1e5 cGy), a rapid increase
in the rate of apoptosis of the intestinal crypts has occurred
mainly in the stem cells of the crypts (Potten & Grant, 1998).
Previously, Drucker and colleagues (Drucker, Erlich, Asa, &
Brubaker, 1996; Tsai, Hill, Asa, Brubaker, & Drucker, 1997)
have reported the growth-promoting properties of GLP-2 and
have shown that it regulates both cell proliferation and
apoptosis and promotes intestinal growth in intact animals.
Similarly, our findings verified that GLP-2 and GLP-1 reduced
the percentage of apoptotic cells after irradiation, demon-
strating a marked reduction in the apoptosis of ileal and
colonic mucosa.
J o u r n a l o f R a d i a t i o n R e s e a r c h and A p p l i e d S c i e n c e s 8 ( 2 0 1 5 ) 2 3 4e2 4 2240In rats that have underwent massive small bowel resec-
tion, GLP-2 has exerted trophic effects on jejunal growth and
improved mucosal glutathione redox status throughout the
bowel (Washizawa et al., 2004). The observations have shown
that GLP-2 is an intestinotrophic peptide stimulating crypt
cell proliferation, nutrient transporter expression, and in-
testinal blood flow (Martin et al., 2004) via specific receptors
on the enteric neurons and enteroendocrine cells (Bjerknes &
Cheng, 2001; Guan et al., 2006). Furthermore, a physiological
role was attributed to GLP-2 in the restoration of epithelial
growth through modulation of crypt-cell proliferation and
villus apoptosis following re-feeding of fasted mice (Shin,
Estall, Izzo, Drucker, & Brubaker, 2005). Independent of its
proliferative actions, GLP-2 has also been shown to produce
anti-inflammatory effects in different models of intestinal
inflammation by improving mucosal healing (Boushey,
Yusta, & Drucker, 1999; Drucker, Yusta, Boushey, DeForest,
& Brubaker, 1999; L'Heureux & Brubaker, 2003), which may
involve its stimulatory effect on mesenteric arterial blood
flow (Deniz, Bozkurt, & Kurtel, 2007). In accordance with the
aforementioned studies, the current study demonstrated that
pretreatment with GLP-2 alleviated irradiation-induced
oxidative damage of the colon and ileum. Similarly, Booth,
Booth, Williamson, Demchyshyn, and Potten (2004) have re-
ported the trophic effects of GLP-2 on the murine small in-
testinal epithelium following whole body irradiation using
the crypt microcolony assay as a measure of stem cell sur-
vival. Furthermore, in rats with chemotherapy-induced en-
teritis GLP-2 has also resulted in an increase in jejunal wet
weight, crypt depth, and villus height (Tavakkolizadeh et al.,
2000; Torres et al., 2007) have demonstrated that GLP-2,
administrated both before and after localized radiation
exposure, reduced the severity of acute and chronic experi-
mental radiation-induced intestinal injury in the rat, but
their observations were only based on macroscopic and
microscopic evaluation of the radiation enteritis. However, in
none of the studies that have shown the intestinotrophic
effects of GLP-2, the antioxidant effect of the peptide was not
studied before.
Although no studies associated with its trophic effects on
the GI cells are present, GLP-1 has also been shown to pro-
duce cytoprotective and antiapoptotic effects in both
pancreatic beta cells and myocardial cells (Bose, Mocanu,
Carr, Brand, & Yellon, 2005; Buteau, Roduit, Susini, &
Prentki, 1999). GLP-1 was reported to activate the epidermal
growth factor receptor (Buteau, Foisy, Joly, & Prentki, 2003)
and stimulate skin and hair growth (List, He, & Habener,
2006). Similar to GLP-2, GLP-1 was also shown to exert anti-
inflammatory effects. Ethanol- or stress-induced gastric
mucosal damage was prevented by GLP-1 (Isbil-Buyukcoskun,
Gulec, Cam-Etoz, & Ozluk, 2009). GLP-1 has increased car-
diomyocyte viability after ischemia-reperfusion injury of
isolated hearts and has reduced myocardial injury in mice
along with increased coronary blood flow (Ban et al., 2008). In
the present study, GLP-1 was efficient to alleviate irradiation-
induced lipid peroxidation and apoptosis in both ileum and
colon.
Tissue MPO activity is frequently utilized to estimate
tissue neutrophil accumulation in inflamed tissues (Bradley
et al., 1982). In the present study, the presence of increasedneutrophil accumulation, as assessed by elevated MPO ac-
tivity in the ileum and colon indicates that radiation-
induced oxidative injury involves the contribution of
neutrophil accumulation. However, the observed reduction
in MPO activity strongly suggests that ongoing neutrophil
recruitment is significantly reduced by GLP-2 therapy, but
not by GLP-1. Thus, the protective effect of GLP-2 against
irradiation involves an inhibitory effect on inflammation-
enhanced MPO activity. On the other hand, GSH, a well-
known antioxidant, provides major protection in oxidative
injury by participating in the cellular system of defense
against oxidative damage (Ross, 1988), while depletion of
tissue GSH is one of the primary factors that permits lipid
peroxidation to occur (Szabo, Nagy, & Plebani, 1992). In the
present study, the decrease in tissue GSH levels may be due
to its consumption during the oxidative stress induced by
irradiation. On the other hand, treatment with GLP-2, but not
GLP-1, prevented GSH depletion or preserved the GSH stores,
suggesting the antioxidant and free-radical scavenging ef-
fect of GLP-2. The present histopathologic results revealed
that radiation-induced intestinal and colonic damage and
inflammation were ameliorated when the animals were
treated with either of the peptides, verifying their protective
effect against radiation injury.
The cellular localization of intestinal GLP-2 receptor
expression has not yet been identified, but it was suggested
that intestinal cells expressing the GLP-2 receptors are likely
to be protected from cell death associated with exposure to
genotoxic stress in vivo (Boushey, Yutsa, & Drucker, 2001).
Given the proliferative effects of GLP-1 and GLP-2, prolonged
therapies with these peptides may be an increased risk for
tumorigenesis (Durai, Yang, Gupta, Seifalian, & Winslet,
2005). A study in mice has shown that GLP-2 administration
can accelerate the growth of chemically induced intestinal
tumors (Thulesen et al., 2004). On the other hand, GLP-2
significantly improved survival, reduced bacterial infection,
and decreased intestinal damage in mice treated with
chemotherapeutic agents, but did not impair chemotherapy
effectiveness in tumor-bearing mice, demonstrating that the
protective effects of GLP-2 are not diminished in the setting
of active tumor (Boushey et al., 2001). Thus, in the current
study the short-term pretreatment with either GLP-1 or GLP-2
before irradiation is not expected to impair radiotherapy
effectiveness.
In conclusion, the most important and innovative conclu-
sion of the present work is that GLP-1 and GLP-2, by their
antioxidant properties, protected the vulnerable intestines
and colon against oxidative damage. These results suggest
that supplementing cancer patients with adjuvant therapy of
these peptides may afford significant protection against
radiation-induced oxidative organ injury.Authors' contributions
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